Publications by authors named "Joshua M Donaldson"

Claim this Profile
H
Highlights of FDA Oncology Approvals in 2023: Bispecific T-cell Engagers, Pediatric Indications, and Inclusive Drug Development.
Joshua M Donaldson, Marjilla Seddiq, Michael J Fusco, Shyamli Singla, Gulsum E Pamuk

Cancer Discov· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies.
Joshua M Donaldson, Cindy Zer, Kendra N Avery, Krzysztof P Bzymek, David A Horne

Proc Natl Acad Sci U S A· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies.
Joshua M Donaldson, Csaba Kari, Ruben C Fragoso, Ulrich Rodeck, John C Williams

Cancer Biol Ther· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced EGFR inhibition and distinct epitope recognition by EGFR antagonistic mAbs C225 and 425.
Vishal Kamat, Joshua M Donaldson, Csaba Kari, Marlene R D Quadros, Peter I Lelkes

Cancer Biol Ther· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis